100 related articles for article (PubMed ID: 2967922)
1. [Advances in the studies of the pathogenesis, treatment and prevention of genetically determined diseases of the extrapyramidal tracts].
Wald I; Markowa J; Kulczycki J
Neurol Neurochir Pol; 1988; 22(1):1-4. PubMed ID: 2967922
[No Abstract] [Full Text] [Related]
2. [Involuntary movements as a complication of treatment of extrapyramidal disorders with L-dopa].
Friedman A; Markowa E
Neurol Neurochir Pol; 1981; 15(4):437-40. PubMed ID: 6460200
[TBL] [Abstract][Full Text] [Related]
3. The pharmacology of extrapyramidal movement disorders.
Klawans HL
Monogr Neural Sci; 1973; 2():1-136. PubMed ID: 4271860
[No Abstract] [Full Text] [Related]
4. Drug-induced extrapyramidal syndromes.
Lader MH
J R Coll Physicians Lond; 1970 Oct; 5(1):87-98. PubMed ID: 4150143
[No Abstract] [Full Text] [Related]
5. Idiopathic torsion dystonia associated with lesions of the basal ganglia.
PeBenito R; Ferretti C; Chaudary RR; Woodrow PK
Clin Pediatr (Phila); 1984 Apr; 23(4):232-5. PubMed ID: 6697632
[TBL] [Abstract][Full Text] [Related]
6. [Clinical picture and course of hereditary extrapyramidal diseases in children].
Bondarenko ES; Malyshev IuI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(10):1458-63. PubMed ID: 930489
[TBL] [Abstract][Full Text] [Related]
7. Hallervorden-Spatz disease and dystonia.
NETSKY MG; SPIRO D; ZIMMERMAN HM
J Neuropathol Exp Neurol; 1951 Apr; 10(2):125-41. PubMed ID: 14824970
[No Abstract] [Full Text] [Related]
8. [Dystonias].
Saïd G
Nouv Presse Med; 1972 Feb; 1(8):527-32. PubMed ID: 4401063
[No Abstract] [Full Text] [Related]
9. [Clinical picture and treatment of Parkinson-like syndromes of hereditary etiology].
Markova ED; Ivanova-Smolenskaia IA; Insarova NG; Barkhatova VP
Klin Med (Mosk); 1978 Sep; 56(9):104-11. PubMed ID: 151762
[No Abstract] [Full Text] [Related]
10. [Serotonin metabolism in several hereditary extrapyramidal diseases].
Markova ED; Solomonov AP; Insarova NG; Larskiĭ EG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(6):830-3. PubMed ID: 130043
[TBL] [Abstract][Full Text] [Related]
11. [Hallervorden-Spatz familial dystonia apropos of a family in which 3 brothers are afflicted. Diagnostic and genetic discussion].
Cruz-Marin F; Gerard M; Brocard O; Gilgenkrantz S; Tridon P; Pierson M
J Genet Hum; 1981 Sep; 29(3):253-8. PubMed ID: 7199561
[No Abstract] [Full Text] [Related]
12. Somatostatin in the treatment of patients with extra-pyramidal disorders and patients with EEG abnormalities.
Dupont E; Hansen AP; Juul-Jensen P; Lundbaek K; Magnussen I; de Fine Olivarius B
Acta Neurol Scand; 1978 Jun; 57(6):488-93. PubMed ID: 151476
[TBL] [Abstract][Full Text] [Related]
13. [Phenomenology of the most important pyramidal and extrapyramidal motoric syndromes. Indications for surgery and results. I].
Mundinger F
Z Allgemeinmed; 1974 Jun; 50(18):827-37. PubMed ID: 4277897
[No Abstract] [Full Text] [Related]
14. [Hallervorden-Spatz disease in twin patients].
Makević M; Dordević D; Jovicić A; Umićević P; Mandić-Gajić G
Vojnosanit Pregl; 1988; 45(4):305-7. PubMed ID: 3188415
[No Abstract] [Full Text] [Related]
15. Hallervorden-Spatz disease.
Miller MB
J Clin Psychiatry; 1989 Aug; 50(8):309. PubMed ID: 2760006
[No Abstract] [Full Text] [Related]
16. Pathology of the torsion dystonias (dystonia musculorum deformans).
Zeman W
Neurology; 1970 Nov; 20(11):79-88. PubMed ID: 5529477
[No Abstract] [Full Text] [Related]
17. [Microelement metabolism in patients with hereditary extrapyramidal diseases].
Borisova TV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(2):217-21. PubMed ID: 147595
[TBL] [Abstract][Full Text] [Related]
18. [Experiences with memantine in the treatment of severe spastic and extrapyramidal movement disorders in combination with stereotaxic surgery].
Mundinger F; Milios E
Nervenarzt; 1985 Feb; 56(2):106-9. PubMed ID: 3885059
[No Abstract] [Full Text] [Related]
19. [The pathogenetic significance of metabolic disorders in hereditary extrapyramial diseases].
Tkachev RA; Markova ED; Gotovtseva EV; Bauman LK; Barkhatova VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):512-20. PubMed ID: 4250562
[No Abstract] [Full Text] [Related]
20. [Experience with using amedin in children with movement disorders of extrapyramidal and labyrinth origin].
Panfilova ZP; Kaganova ED; Skubak VV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(10):1495-7. PubMed ID: 716725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
